news

Jan 15 2018
Cingulate Therapeutics Presents New Data from its First in Human Proof of Concept Trial of CTX-1301 at the 2018 APSARD Annual Meeting

Jan 9 2018
Rebiotix Highlights 2017 Achievements and 2018 Objectives

Jan 9 2018
Cingulate Therapeutics Appoints Experienced Lead Investigator Matthew Brams, MD as Chief Medical Officer


 

events

Jan 29-30 2018
Noble Financial 14th Annual Equity Conference

Feb 5-7 2018
North American Microbiome Congress

Feb 5-7 2018
Immuno-Oncology 360°

Feb 12-13 2018
BIO CEO & Investor Conference


 

spotlight